Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
72
COFS Quote, Financials, Valuation and Earnings
Last price:
$35.63
Seasonality move
:
-2.88%
Day range:
$33.97 - $36.26
52-week range:
$21.52 - $38.15
Dividend yield:
3.04%
P/E ratio:
11.36x
P/S ratio:
3.18x
P/B ratio:
1.30x
Volume:
119.5K
Avg. volume:
28.7K
1-year change:
18.06%
Market cap:
$321.5M
Revenue:
$80.8M
EPS (TTM):
$3.16
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $36.9M | $73.8M | $79.8M | $81.4M | $80.8M | |
| Revenue Growth (YoY) | 27.45% | 99.69% | 8.22% | 1.94% | -0.73% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15M | $27.6M | $31M | $31.9M | $33.9M | |
| Other Inc / (Exp) | $22K | $1.2M | $439K | -$1.8M | -$317K | |
| Operating Expenses | $15.3M | $29.1M | $32.3M | $33M | $34.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.5M | $18.9M | $26.5M | $27.7M | $25.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3M | $3.3M | $4.5M | $4M | $4.3M | |
| Net Income to Company | $7.2M | $15.6M | $22M | $23.6M | $21.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.2M | $15.6M | $22M | $23.6M | $21.3M | |
| Basic EPS (Cont. Ops) | $1.58 | $2.08 | $2.87 | $3.15 | $2.82 | |
| Diluted EPS (Cont. Ops) | $1.58 | $2.07 | $2.86 | $3.15 | $2.82 | |
| Weighted Average Basic Share | $4.5M | $7.5M | $7.7M | $7.5M | $7.5M | |
| Weighted Average Diluted Share | $4.5M | $7.5M | $7.7M | $7.5M | $7.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $13.2M | $23.5M | $30.5M | $35.4M | $58.7M | |
| Revenue (Reported) | $36.9M | $73.8M | $79.8M | $81.4M | $80.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $13.2M | $23.5M | $30.5M | $35.4M | $58.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $20.4M | $20.4M | $20.4M | $19.9M | $25.1M | |
| Revenue Growth (YoY) | 171.66% | 0.15% | -0.16% | -2.23% | 26.02% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.4M | $8M | $8.1M | $8.6M | $8.9M | |
| Other Inc / (Exp) | -$273K | -$28K | -$701K | -$205K | $277K | |
| Operating Expenses | $8.8M | $8.3M | $8.4M | $8.8M | $8.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.6M | $6.9M | $6.9M | $6.2M | $9.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $785K | $1.2M | $1.1M | $1.1M | $1.9M | |
| Net Income to Company | $3.8M | $5.7M | $5.8M | $5.1M | $7.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.8M | $5.7M | $5.8M | $5.1M | $7.3M | |
| Basic EPS (Cont. Ops) | $0.49 | $0.75 | $0.77 | $0.68 | $0.86 | |
| Diluted EPS (Cont. Ops) | $0.49 | $0.75 | $0.77 | $0.68 | $0.85 | |
| Weighted Average Basic Share | $7.8M | $7.6M | $7.5M | $7.5M | $8.6M | |
| Weighted Average Diluted Share | $7.8M | $7.6M | $7.5M | $7.6M | $8.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.7M | $7.9M | $8.8M | $16.3M | $20.7M | |
| Revenue (Reported) | $20.4M | $20.4M | $20.4M | $19.9M | $25.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.7M | $7.9M | $8.8M | $16.3M | $20.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $68.7M | $79.6M | $80.2M | $81.3M | $88.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $25.9M | $30.1M | $32.1M | $33.3M | $34.7M | |
| Other Inc / (Exp) | $1M | $493K | -$1.8M | -$480K | $451K | |
| Operating Expenses | $27.4M | $31.5M | $33.3M | $34.3M | $34.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $17.6M | $25.3M | $26M | $26.9M | $30.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.1M | $4.1M | $4.1M | $4.2M | $5.9M | |
| Net Income to Company | $14.5M | $21.1M | $22M | $22.7M | $24.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.5M | $21.1M | $22M | $22.7M | $24.9M | |
| Basic EPS (Cont. Ops) | $1.99 | $2.73 | $2.93 | $3.01 | $3.18 | |
| Diluted EPS (Cont. Ops) | $1.99 | $2.72 | $2.92 | $3.01 | $3.16 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.9M | $29.2M | $31.6M | $51.8M | $77.1M | |
| Revenue (Reported) | $68.7M | $79.6M | $80.2M | $81.3M | $88.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.9M | $29.2M | $31.6M | $51.8M | $77.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $54.1M | $59.9M | $60.3M | $60.2M | $68.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $20.3M | $22.8M | $23.9M | $25.3M | $26.1M | |
| Other Inc / (Exp) | $1.1M | $464K | -$1.8M | -$527K | $241K | |
| Operating Expenses | $21.4M | $23.8M | $24.8M | $26.1M | $26.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14M | $20.4M | $19.9M | $19.1M | $24.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.5M | $3.3M | $3M | $3.2M | $4.7M | |
| Net Income to Company | $11.5M | $17M | $17M | $16M | $19.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $11.5M | $17M | $17M | $16M | $19.6M | |
| Basic EPS (Cont. Ops) | $1.55 | $2.20 | $2.26 | $2.12 | $2.48 | |
| Diluted EPS (Cont. Ops) | $1.55 | $2.20 | $2.26 | $2.12 | $2.46 | |
| Weighted Average Basic Share | $22.3M | $23.2M | $22.5M | $22.6M | $23.7M | |
| Weighted Average Diluted Share | $22.3M | $23.2M | $22.5M | $22.7M | $23.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $17.6M | $23.3M | $24.4M | $40.8M | $59.3M | |
| Revenue (Reported) | $54.1M | $59.9M | $60.3M | $60.2M | $68.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $17.6M | $23.3M | $24.4M | $40.8M | $59.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $59.6M | $79.5M | $31.9M | $43.9M | $55.4M | |
| Short Term Investments | $339.6M | $574.8M | $1.1B | $529.7M | $514.6M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $399.1M | $654.3M | $1.1B | $573.7M | $570M | |
| Property Plant And Equipment | $24.3M | $29.5M | $29.9M | $28.2M | $29.8M | |
| Long-Term Investments | $342.4M | $577.7M | $1.1B | $964.2M | $930.1M | |
| Goodwill | $52.9M | $60.5M | $59.9M | $59.9M | $59.9M | |
| Other Intangibles | $6M | $5.3M | $4M | $2.8M | $1.9M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.4B | $1.9B | $2.4B | $2.4B | $2.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $33M | -- | $50M | $50M | $30M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $33M | -- | $50M | $50M | $30M | |
| Long-Term Debt | $198K | $12.4M | $35M | $35.3M | $205.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.2B | $1.7B | $2.1B | $2.2B | $2.4B | |
| Common Stock | $162.6M | $178.8M | $171.9M | $172.3M | $173.5M | |
| Other Common Equity Adj | $1.5M | $11M | -$2.6M | -$71.8M | -$51.6M | |
| Common Equity | $192.1M | $227.3M | $221.7M | $168.9M | $195.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $192.1M | $227.3M | $221.7M | $168.9M | $195.6M | |
| Total Liabilities and Equity | $1.4B | $1.9B | $2.4B | $2.4B | $2.6B | |
| Cash and Short Terms | $399.1M | $654.3M | $1.1B | $573.7M | $570M | |
| Total Debt | $33.2M | $12.4M | $85M | $85.3M | $235.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $117.9M | $59.8M | $51.5M | $144.7M | $145.9M | |
| Short Term Investments | $393.3M | $1B | $530.1M | $490.8M | $497.6M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $511.2M | $1.1B | $581.6M | $635.5M | $643.5M | |
| Property Plant And Equipment | $29.9M | $30M | $28.9M | $29.6M | $27.1M | |
| Long-Term Investments | $396M | $1B | $966.3M | $912.8M | $897.3M | |
| Goodwill | $60.5M | $59.9M | $59.9M | $59.9M | $59.9M | |
| Other Intangibles | $5.7M | $4.3M | $3.1M | $2.1M | $1.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.8B | $2.3B | $2.4B | $2.6B | $2.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $190M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $190M | |
| Long-Term Debt | $13.2M | $35M | $35.2M | $215.4M | $55.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $2.1B | $2.2B | $2.4B | $2.5B | |
| Common Stock | $178.6M | $173.9M | $172M | $173.2M | $206.4M | |
| Other Common Equity Adj | $9.3M | $2M | -$79M | -$62.5M | -$45.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $222.9M | $225.1M | $156.7M | $181.2M | $247.7M | |
| Total Liabilities and Equity | $1.8B | $2.3B | $2.4B | $2.6B | $2.7B | |
| Cash and Short Terms | $511.2M | $1.1B | $581.6M | $635.5M | $643.5M | |
| Total Debt | $13.2M | $35M | $35.2M | $215.4M | $245.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2M | $15.6M | $22M | $23.6M | $21.3M | |
| Depreciation & Amoritzation | $3.1M | $7.7M | $12.4M | $13.3M | $12.4M | |
| Stock-Based Compensation | $373K | $512K | $812K | $958K | $1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.2M | $8.5M | $37.7M | $45M | $46.5M | |
| Capital Expenditures | $766K | $1.9M | $2.8M | $1.2M | $4.2M | |
| Cash Acquisitions | $20.6M | $35.6M | -- | -- | -- | |
| Cash From Investing | $36.4M | -$250.8M | -$521.4M | -$90.5M | -$181.4M | |
| Dividends Paid (Ex Special Dividend) | -$5.8M | -$6.2M | -$7.2M | -$7.6M | -$7.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $115M | $10.1M | $87.5M | $726M | $420M | |
| Long-Term Debt Repaid | -$110M | -$33.9M | -$14.3M | -$726M | -$270M | |
| Repurchase of Common Stock | -$364K | -- | -$7.8M | -$682K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5.7M | $262.2M | $436M | $57.5M | $146.4M | |
| Beginning Cash (CF) | $19.7M | $59.6M | $79.5M | $31.9M | $43.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $39.9M | $20M | -$47.6M | $12.1M | $11.5M | |
| Ending Cash (CF) | $59.6M | $79.5M | $31.9M | $43.9M | $55.4M | |
| Levered Free Cash Flow | $8.4M | $6.6M | $34.9M | $43.9M | $42.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.8M | $5.7M | $5.8M | $5.1M | $7.3M | |
| Depreciation & Amoritzation | $2M | $3.3M | $3.3M | $3.1M | $3.1M | |
| Stock-Based Compensation | $154K | $192K | $233K | $254K | -$35K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$15M | $12.4M | $9.7M | $32.2M | -$6.4M | |
| Capital Expenditures | $624K | $732K | $537K | $1.2M | $253K | |
| Cash Acquisitions | $35.6M | -- | -- | -- | -- | |
| Cash From Investing | $33.3M | -$204M | -$7.7M | -$29.2M | -$60.3M | |
| Dividends Paid (Ex Special Dividend) | -$1.6M | -$1.9M | -$1.9M | -$2M | -$2.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$2.7M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $32.7M | $156M | $9.2M | $64.9M | $111.6M | |
| Beginning Cash (CF) | $66.8M | $95.3M | $40.3M | $76.8M | $101M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $51.1M | -$35.5M | $11.2M | $67.9M | $44.9M | |
| Ending Cash (CF) | $117.9M | $59.8M | $51.5M | $144.7M | $145.9M | |
| Levered Free Cash Flow | -$15.6M | $11.7M | $9.2M | $30.9M | -$6.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.5M | $21.1M | $22M | $22.7M | $24.9M | |
| Depreciation & Amoritzation | $6.8M | $11.2M | $13.7M | $12.5M | $12.3M | |
| Stock-Based Compensation | $282K | $771K | $942K | $973K | $805K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$16.5M | $58.3M | $40.2M | $70.3M | $13.8M | |
| Capital Expenditures | $1.9M | $2.5M | $1.8M | $3.4M | $1.8M | |
| Cash Acquisitions | $56.3M | -- | -- | -- | -- | |
| Cash From Investing | -$70.1M | -$551.3M | -$183.3M | -$126.1M | -$141.6M | |
| Dividends Paid (Ex Special Dividend) | -$5.9M | -$7M | -$7.5M | -$7.8M | -$8.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$53M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$5.6M | -$2.9M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $187.9M | $434.9M | $134.9M | $149M | $129M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $101.3M | -$58.1M | -$8.3M | $93.2M | $1.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$18.3M | $55.8M | $38.4M | $66.9M | $12M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.5M | $17M | $17M | $16M | $19.6M | |
| Depreciation & Amoritzation | $5.4M | $8.9M | $10.2M | $9.3M | $9.2M | |
| Stock-Based Compensation | $337K | $596K | $726K | $741K | $541K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$20.3M | $29.6M | $32M | $57.3M | $24.6M | |
| Capital Expenditures | $1.6M | $2.2M | $1.2M | $3.5M | $1M | |
| Cash Acquisitions | $35.6M | -- | -- | -- | -- | |
| Cash From Investing | -$98M | -$398.6M | -$60.5M | -$96.1M | -$56.3M | |
| Dividends Paid (Ex Special Dividend) | -$4.5M | -$5.3M | -$5.6M | -$5.9M | -$6.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $10M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$33M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$5.6M | -$682K | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $176.6M | $349.3M | $48.1M | $139.5M | $122.2M | |
| Beginning Cash (CF) | $171.8M | $310.2M | $162.2M | $175.9M | $306.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $58.3M | -$19.7M | $19.6M | $100.7M | $90.5M | |
| Ending Cash (CF) | $230.1M | $290.4M | $181.8M | $276.7M | $397.1M | |
| Levered Free Cash Flow | -$21.8M | $27.4M | $30.8M | $53.9M | $23.6M | |
Get COFS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
COFS
Sector
P/E ratio
11.36x
12.02x
PEG ratio
2.28x
0.36x
P/B ratio
1.30x
1.05x
Price / LTM sales
3.18x
2.55x
Growth Metrics
COFS
Sector
Revenue growth
26.02%
6.08%
Earnings growth
25%
6.45%
Revenue (5-year growth)
22.76%
5.85%
Earnings forecast
$0.74
$0.56
Profitability
COFS
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
5.57%
5.27%
Return on assets
0.94%
0.98%
Return on equity
11.89%
9.43%
Earnings Date
Last Earnings Date
Oct
23
Next Earnings Date
Jan
24
Estimated Next Earnings Date
Jan
22
Balance Sheet
COFS
Sector
Total cash
$643.5M
$617M
Short term investments
$514.6M
$408.4M
Total assets
$2.6B
$4.5B
Long term debt
$245.7M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
